jeudi 29 octobre 2015

Onco Actu du 29 octobre 2015

2.11 Etiologie - Alimentation

Meat as a Cause of Cancer [NY Times]

3.1 Tabac

E-Cigarettes Appeal to Smokers Who Are Trying to Quit, Study Says [Wall Street Journal]

4.9 Dép., diag. & prono. - Sein

This may explain why more deaths aren't prevented by breast cancer screening [LA Times]

Mammograms not catching worst cancers before they spread -US study [The Guardian]

5.10 Traitements - Essais

Landmark clinical trial shows gene-targeted drug can treat prostate cancer [The Institute of Cancer Research]

Men with advanced prostate cancer could benefit from ‘targeted’ drug [Cancer Research UK]

'Milestone' prostate cancer drug [BBC News]

5.12 Immunothérapies

Amgen's Imlygic May Not Boost Earnings But It Will Change Cancer Care [Forbes]

FDA Approves First in a New Class of Immunotherapies [CRI]

5.2 Pharma

Bristol-Myers Squibb’s Opdivo (nivolumab) Recipient of Prix Galien USA 2015 Award for Best Biotechnology Product [BMS]

IMBRUVICA® (ibrutinib) Awarded Prix Galien 2015 Best Pharmaceutical Agent [AbbVie]

5.2.1 Pharma - Partenariats

Servier severs a $450M oncology deal with MacroGenics [FierceBiotech]

5.3 Traitements - FDA, EMA,...

EMA launches scheme to prioritise medicines access for patients [Pharmafile]

FDA Seeks Info on New Tech Helping Conduct Clinical Research [RAPS]

5.3.4 Traitements - AMM (FDA, EMA)

Bristol-Myers Squibb Receives Approval from the U.S. Food and Drug Administration for Yervoy (ipilimumab) as Adjuvant Treatment for Fully Resected Stage III Melanoma [BMS]

FDA approves Yervoy to reduce the risk of melanoma returning after surgery [FDA]

FDA expands use of Bristol Myers' cancer drug Yervoy [Reuters]

6.1 Observation

Where cancer patients live could influence late diagnosis [Cancer Research UK]

6.11 Patients

How cancer treatments can affect your sex life [The Globe and Mail]

6.4 Médico-éco

$20 million Commonwealth Foundation for Cancer Research gift to expand collaborative cancer research [MIT News]